2014年1月–至今，南京大学，医学院，副教授，硕士生导师 2008年12月–2013年12月，南京大学，医学院，讲师 2007年9月–2008年9月，Northwestern University, Feinberg School of Medicine, 访问学习

主持国家自然科学基金青年科学基金项目1项，教育部博士点新教师基金1项1. 国家自然科学基金青年科学基金项目，81100386、Th17/Treg平衡对造血干细胞移植诱导1型糖尿病免疫耐受影响的研究、2012/01-2014/12、主持。

2. 教育部博士点新教师基金，20110091120031、Th17/Treg平衡对造血干细胞移植诱导1型糖尿病免疫耐受影响的研究、2012/01-2014/12、主持。

3. 中央高校基本科研业务费项目，Treg输注联合造血干细胞移植治疗糖尿病肾病的研究、201409-201712、主持。

发表SCI论著14篇. Wen YT, Dai JH, Gao Q. Effects of Omega-3 fatty acid on major cardiovascular events and mortality for patients with coronary heart disease: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2014 May;24(5):470-5.

2. Ma X, Ding J, Min H, Wen Y, Gao Q. Protective role of low-dose TGF-β1 in early diabetic nephropathy induced by streptozotocin. Int Immunopharmacol. 2013 Nov;17(3):752-8. (通讯作者)

3. Wen Y, Xu J, Ma X, Gao Q. High-Dose Erythropoietin in Acute ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials. Am J Cardiovasc Drugs. 2013 Dec;13(6):435-42.

4. Wen Y, Chen B, Wang C, Ma X, Gao Q. Bone marrow-derived mononuclear cell therapy for patients with ischemic heart disease and ischemic heart failure. Expert Opin Biol Ther. 2012; 12(12):1563-73.

5. Li J, Xu H, Gao Q, Wen Y. Effect of erythropoiesis-stimulating agents in acute ST-segment elevation myocardial infarction: a systematic review. Eur J Clin Pharmacol. 2012; 68(5):469-77. (通讯作者)

6. Wen Y, Meng L, Gao Q. Autologous bone marrow cell therapy for patients with peripheral arterial disease: a meta-analysis of randomized controlled trials. Expert Opin Biol. Ther. 2011; 11(12):1-9.

7. Wen Y, Meng L, Ding Y, Ouyang J. Autologous transplantation of blood-derived stem/progenitor cells for ischaemic heart disease. Int J Clin Pract. 2011; 65(8): 858–65.

8. Wen Y, Meng L, Xie J, Ouyang J. Direct Autologous bone marrow-derived stem cell transplantation for ischemic Heart Disease: a meta-analysis. Expert Opin Biol Ther. 2011; 11(5):559-67.

9. Wen Y, Ouyang J, Li W, Chen J, Liu Y, Meng L, Zhang H, Zhou X. Time point is important for effects of syngeneic bone marrow transplantation for type 1 diabetes in mice. Transplant Proc. 2009 Jun; 41(5):1801-7.

10. Wen Y, Ouyang J, Yang R, Chen J, Liu Y, Zhou X, Burt RK. Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation. Biochem Biophys Res Commun. 2008; 374(2):282-7.